Lack of the antianxiety-like effect of (S)-3,4-DCPG, an mGlu8 receptor agonist, after central administration in rats

Pharmacol Rep. 2005 Nov-Dec;57(6):856-60.

Abstract

Substances acting as agonists of group III mGlu receptors were shown to induce an antianxiety-like effect after intrahippocampal administration to rats. The purpose of the present study was to establish whether the selective mGlu8 receptor agonist (S)-3,4-dicarboxyphenylglycine ((S)-3,4-DCPG) induced an anxiolytic-like effect after injection into the basolateral amygdala nuclei or the CA1 region of the hippocampus in the conflict drinking Vogel test in rats. The obtained results indicate that (S)-3,4-DCPG (10, 50 and 100 nmol/rat) produces no anticonflict effect in rats. We conclude that selective stimulation of mGlu8 receptors (a subtype of group III mGluRs) does not evoke anxiolytic-like activity, and that the mGlu8 receptors are of no significance for anxiolytic-like effects of group III mGluR agonists.

MeSH terms

  • Amygdala / drug effects*
  • Amygdala / metabolism
  • Animals
  • Anti-Anxiety Agents / administration & dosage
  • Anti-Anxiety Agents / pharmacology*
  • Benzoates / administration & dosage
  • Benzoates / pharmacology*
  • Conflict, Psychological
  • Drinking Behavior / drug effects
  • Electroshock
  • Glycine / administration & dosage
  • Glycine / analogs & derivatives*
  • Glycine / pharmacology
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Injections, Intraventricular
  • Male
  • Rats
  • Rats, Wistar
  • Receptors, Metabotropic Glutamate / antagonists & inhibitors*
  • Receptors, Metabotropic Glutamate / metabolism

Substances

  • 3,4-dicarboxyphenylglycine
  • Anti-Anxiety Agents
  • Benzoates
  • Receptors, Metabotropic Glutamate
  • metabotropic glutamate receptor 8
  • Glycine